青少年和护理人员对青少年异常性关节炎治疗的偏好:一个离散选择实验
Flora McErlane1, Marco Boeri2,3,4, Cooper Bussberg5
1Paediatric Rheumatology Department, Great North Children's Hospital, Newcastle Upon Tyne, UK.
Pediatric rheumatology online journal
|October 21, 2023
概括
患有青春性异常性关节炎 (JIA) 的患者及其护理人员优先考虑症状控制和较少的副作用,而不是施用方法. 对JIA治疗的偏好因地区和患者特征而异.
科学领域:
- 类风湿病学 类风湿病学
- 儿科健康 儿科健康
- 患者报告的结果
背景情况:
- 青少年异常性关节炎 (JIA) 是一种慢性疾病,影响儿童和青少年.
- 了解患者和护理人员的偏好对于优化JIA治疗方案至关重要.
研究的目的:
- 在美国和英国的青少年和护理人员中引起和量化JIA治疗的偏好.
- 确定影响JIA治疗选择的关键属性.
主要方法:
- 在美国,对197名青少年和207名护理人员进行了离散选择实验,在英国,对100名青少年和200名护理人员进行了离散选择实验.
- 受访者评估了假设的JIA治疗概况,其疗效,副作用,剂量和治疗类型各不相同.
- 一个随机参数逻辑模型分析了偏好权重和条件相对重要性.
主要成果:
- 更大的症状控制和更长的时间,直到下一次爆发是首选的.
- 胃痛,恶心,吐和头痛的发病率降低受到高度重视.
- 美国和英国的参与者之间以及青少年和护理人员之间,对施用方式和组合治疗的偏好有所不同.
- 在人口统计和临床子组中观察到显著的偏好异质性.
结论:
- 在JIA治疗中,有效的症状管理和减少不良事件至关重要.
- 治疗偏好是复杂的,受到地理位置,年龄和治疗史的影响.
- 根据个体患者和护理人员的偏好量身定制JIA治疗策略,可以提高患者的坚持和结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
170
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
170
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
122
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
122
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11
Chronic Kidney Disease III: Interprofessional Care
21
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
21


